Home » Authors » Brady Huggett

Articles by Brady Huggett

London AIM Market Gaining Weight, Challenging Nasdaq

July 3, 2006

By Brady Huggett

London AIM Market Gaining Weight, Challenging Nasdaq

July 3, 2006

By Brady Huggett

Pharma's Antibody Hunger Behind Technology Buyouts

June 19, 2006

By Brady Huggett

Pharma's Shopping Continues, With Focus On Antibody Firms

June 16, 2006

By Brady Huggett

Pharma's Shopping Continues, With Focus On Antibody Firms

June 16, 2006

By Brady Huggett

With IPO Investors Stingy, Trubion Seeking $86.25M

June 8, 2006

By Brady Huggett

With IPO Investors Stingy, Trubion Seeking $86.25M

June 8, 2006

By Brady Huggett

Biogen Buying Fumapharm, Consolidating BG-12 Rights

June 7, 2006

By Brady Huggett

Biogen Buying Fumapharm, Consolidating BG-12 Rights

June 7, 2006

By Brady Huggett

Biogen Buying Fumapharm, Consolidating BG-12 Rights

June 1, 2006

By Brady Huggett

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...